Novartis Raises Guidance on Profit, Sales Growth
By Helena Smolak
Novartis lifted its full-year guidance after first-quarter profit and sales rose and beat consensus expectations, boosted by strong sales of key drugs.
The Swiss pharmaceutical major said Tuesday that it now projects net sales in 2024 to grow in the high-single to low double-digit range, after previously guiding for growth in the mid-single-digit percentage range.
Novartis now expects core operating income growth in the low double-digit to mid-teens range, having previously expected high single-digits growth.
Its core operating profit--one of its preferred earnings metrics, which strips out exceptional items--rose 16% on year in the first quarter to $4.54 billion, excluding its former generics drugs business Sandoz, which was spun-off last October.
Sales climbed to $11.83 billion from $10.80 billion, excluding Sandoz. Strong growth in sales of the company's Entresto heart drug and Cosentyx psoriasis treatment, which both topped $1 billion in quarterly revenue, helped the top line.
Analysts polled by Visible Alpha had forecast the company's first-quarter core operating profit at $4.245 billion and sales at $11.38 billion.
Write to Helena Smolak at helena.smolak@wsj.com
(END) Dow Jones Newswires
April 23, 2024 01:39 ET (05:39 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing